US research roundup: Lexeo Therapeutics, Newmont, Tyson Foods
LXEO•Analysts raised Lexeo Therapeutics’ price targets to $23 from $15 and $42 from $24, cut Newmont’s to $149 from $155, and raised Tyson Foods’ to $72 from $56. The roundup also lists research actions on 21 other US-listed companies.




